Alison Harrod

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

The SMARCA4 subunit of the SWI/SNF complex prevents genome instability at G quadruplexes.

The SMARCA4 subunit of the SWI/SNF complex prevents genome instability at G quadruplexes.

Journal: Genome biology
Published: October 17, 2025

ARID1A stabilizes non-homologous end joining factors at DNA breaks induced by the G4 ligand pyridostatin.

ARID1A stabilizes non-homologous end joining factors at DNA breaks induced by the G4 ligand pyridostatin.

Journal: Cell reports
Published: June 12, 2025

Boundary issues: SWI/SNF shapes chromatin patterns in and around centromeres.

Boundary issues: SWI/SNF shapes chromatin patterns in and around centromeres.

Journal: Open biology
Published: May 30, 2025

PBRM1 directs PBAF to pericentromeres and protects centromere integrity.

PBRM1 directs PBAF to pericentromeres and protects centromere integrity.

Journal: Nature communications
Published: June 29, 2024

Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling.

Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling.

Journal: Scientific reports
Published: October 31, 2022

Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer.

Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer.

Journal: Oncogene
Published: July 02, 2022

MicroRNA-495/TGF-β/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cells.

MicroRNA-495/TGF-β/FOXC1 axis regulates multidrug resistance in metaplastic breast cancer cells.

Journal: Biochemical pharmacology
Published: April 30, 2021

The role of the SWI/SNF chromatin remodelling complex in the response to DNA double strand breaks.

The role of the SWI/SNF chromatin remodelling complex in the response to DNA double strand breaks.

Journal: DNA repair
Published: October 22, 2020

ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

Journal: Molecular cancer therapeutics
Published: December 07, 2016

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.

Journal: Nature communications
Published: October 13, 2016

Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.

Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer.

Journal: Oncogene
Published: June 03, 2016

APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.

APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer.

Journal: Cell reports
Published: May 14, 2015
Showing 1-12 of 13

Last Updated: 09/26/2026